China has installed the final steam generator at Zhangzhou unit 3, the third of six planned Hualong One reactors at the ...

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...

Novo Nordisk has announced plans to move its ziltivekimab into phase 3 clinical development in atherosclerosis with chronic kidney disease after a mid-stage trial met its main goal. The Danish pharma ...

They say the sedan is dead, but Toyota's 2026 portfolio suggests ...

Abstract: High-speed and high-power motor drive systems are critical for applications such as electric vehicles and industrial automation. These systems often utilize synchronous space vector pulse ...

ANDRITZ is investing a higher double-digit million euro amount by 2028 to expand and modernise its turbo generator production facilities in Linz and Weiz, responding to rising global energy demand and ...